These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth. Lin R; Tao R; Gao X; Li T; Zhou X; Guan KL; Xiong Y; Lei QY Mol Cell; 2013 Aug; 51(4):506-518. PubMed ID: 23932781 [TBL] [Abstract][Full Text] [Related]
3. Acetylation of Mitochondrial Trifunctional Protein α-Subunit Enhances Its Stability To Promote Fatty Acid Oxidation and Is Decreased in Nonalcoholic Fatty Liver Disease. Guo L; Zhou SR; Wei XB; Liu Y; Chang XX; Liu Y; Ge X; Dou X; Huang HY; Qian SW; Li X; Lei QY; Gao X; Tang QQ Mol Cell Biol; 2016 Oct; 36(20):2553-67. PubMed ID: 27457618 [TBL] [Abstract][Full Text] [Related]
4. In Steatotic Cells, ATP-Citrate Lyase mRNA Is Efficiently Translated through a Cap-Independent Mechanism, Contributing to the Stimulation of De Novo Lipogenesis. Siculella L; Giannotti L; Testini M; Gnoni GV; Damiano F Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054087 [TBL] [Abstract][Full Text] [Related]
5. Bempedoic Acid Unveils Therapeutic Potential in Non-Alcoholic Fatty Liver Disease: Suppression of the Hepatic PXR-SLC13A5/ACLY Signaling Axis. Sun Q; Guo Y; Hu W; Zhang M; Wang S; Lei Y; Meng H; Li N; Xu P; Li Z; Lin H; Huang F; Qiu Z Drug Metab Dispos; 2023 Dec; 51(12):1628-1641. PubMed ID: 37684055 [TBL] [Abstract][Full Text] [Related]
6. Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice. Li K; Zhang K; Wang H; Wu Y; Chen N; Chen J; Qiu C; Cai P; Li M; Liang X; Su D Metabolism; 2021 Jan; 114():154349. PubMed ID: 32888949 [TBL] [Abstract][Full Text] [Related]
7. Sirtuin 2 Prevents Liver Steatosis and Metabolic Disorders by Deacetylation of Hepatocyte Nuclear Factor 4α. Ren H; Hu F; Wang D; Kang X; Feng X; Zhang L; Zhou B; Liu S; Yuan G Hepatology; 2021 Aug; 74(2):723-740. PubMed ID: 33636024 [TBL] [Abstract][Full Text] [Related]
8. Regulation on Citrate Influx and Metabolism through Inhibiting SLC13A5 and ACLY: A Novel Mechanism Mediating the Therapeutic Effects of Curcumin on NAFLD. Sun Q; Niu Q; Guo Y; Zhuang Y; Li X; Liu J; Li N; Li Z; Huang F; Qiu Z J Agric Food Chem; 2021 Aug; 69(31):8714-8725. PubMed ID: 34323067 [TBL] [Abstract][Full Text] [Related]
9. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice. Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596 [TBL] [Abstract][Full Text] [Related]
10. Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice. Yenilmez B; Kelly M; Zhang GF; Wetoska N; Ilkayeva OR; Min K; Rowland L; DiMarzio C; He W; Raymond N; Lifshitz L; Pan M; Han X; Xie J; Friedline RH; Kim JK; Gao G; Herman MA; Newgard CB; Czech MP J Biol Chem; 2022 Oct; 298(10):102401. PubMed ID: 35988648 [TBL] [Abstract][Full Text] [Related]
11. SIRT2-mediated deacetylation of ACLY promotes the progression of oesophageal squamous cell carcinoma. Zhang X; Xu Y; Li S; Qin Y; Zhu G; Zhang Q; Zhang Y; Guan F; Fan T; Liu H J Cell Mol Med; 2024 Mar; 28(6):e18129. PubMed ID: 38426936 [TBL] [Abstract][Full Text] [Related]
12. ATP Citrate Lyase and LncRNA NONMMUT010685 Play Crucial Role in Nonalcoholic Fatty Liver Disease Based on Analysis of Microarray Data. Ma TT; Huang C; Ni Y; Yang Y; Li J Cell Physiol Biochem; 2018; 51(2):871-885. PubMed ID: 30466110 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells. Migita T; Okabe S; Ikeda K; Igarashi S; Sugawara S; Tomida A; Soga T; Taguchi R; Seimiya H Int J Cancer; 2014 Jul; 135(1):37-47. PubMed ID: 24310723 [TBL] [Abstract][Full Text] [Related]
14. S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis. Zhang L; Zhang Z; Li C; Zhu T; Gao J; Zhou H; Zheng Y; Chang Q; Wang M; Wu J; Ran L; Wu Y; Miao H; Zou X; Liang B Cell Mol Gastroenterol Hepatol; 2021; 11(3):697-724. PubMed ID: 33075563 [TBL] [Abstract][Full Text] [Related]
15. Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression. Noh KH; Kang HM; Yoo W; Min Y; Kim D; Kim M; Wang S; Lim JH; Jung CR Metabolism; 2020 Sep; 110():154302. PubMed ID: 32589900 [TBL] [Abstract][Full Text] [Related]
16. SIRT2 Deficiency Aggravates Diet-Induced Nonalcoholic Fatty Liver Disease through Modulating Gut Microbiota and Metabolites. Li X; Du Y; Xue C; Kang X; Sun C; Peng H; Fang L; Han Y; Xu X; Zhao C Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240315 [TBL] [Abstract][Full Text] [Related]
17. LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease. Lee J; Kim H; Kang YW; Kim Y; Park MY; Song JH; Jo Y; Dao T; Ryu D; Lee J; Oh CM; Park S Exp Mol Med; 2023 Jul; 55(7):1479-1491. PubMed ID: 37394588 [TBL] [Abstract][Full Text] [Related]
18. Mammalian SIRT6 Represses Invasive Cancer Cell Phenotypes through ATP Citrate Lyase (ACLY)-Dependent Histone Acetylation. Zheng W; Tasselli L; Li TM; Chua KF Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573442 [TBL] [Abstract][Full Text] [Related]
19. SIRT2 Deficiency Exacerbates Hepatic Steatosis via a Putative Role of the ER Stress Pathway. Leal H; Cardoso J; Valério P; Quatorze M; Carmona V; Cunha-Santos J; Pereira de Almeida L; Pereira C; Cavadas C; Gomes P Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743232 [TBL] [Abstract][Full Text] [Related]